OsteoarthritisNCT00391365
Treatment Outcomes for Ankle Arthritis
An observational study of Osteoarthritis, run by VA Office of Research and Development at 1 site in United States.
Trial summary
The purpose of this study is to determine any functional outcome differences in patients who have undergone surgical treatment for ankle osteoarthritis using surveys, step counts, and laboratory gait analysis. Read more about this study
- Who is it for?
- Ages 18 to 89 years
- Conditions the study is for
- Osteoarthritis
- What is being tested?
- Gait analysis
- Type of treatment
- Surgery or procedure
- How many people
- 368 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Mar 2005to 31 Dec 2025
- Phase
- Observational
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 89 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Subjects with ankle osteoarthritis who will undergo either ankle arthrodesis (fusion) or ankle arthroplasty (replacement)
Who may be able to join
- Ankle arthritis subjects will be recruited from patients at
- VA Puget Sound Health Care System (Seattle, WA)
- Harborview Medical Center (Seattle, WA)
- Orthopaedic Associates of Michigan (Grand Rapids, MI)
- Orthopedic + Fracture Specialists (Portland, OR)
- Twin Cities Orthopedics (Edina, MN)
Show all 12Show fewer
- who have been diagnosed with end stage ankle arthrosis
- are ambulatory
- speak English
- are cognitively intact
- between the ages of 18-89
- and have elected to undergo surgical correction (arthrodesis or arthroplasty) for end-stage ankle arthritis
Who cannot join
- Suffer from Rheumatoid Arthritis or other systemic arthritis
- Have any other diseased lower extremity joints or traumatic lower extremity injury that grossly inhibits normal gait
Trial locations and contacts
1 site in 1 country.
United States1 site
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, 98108-1532
About this study
The purpose of this study is to determine any functional outcome differences in patients who have undergone surgical treatment for ankle osteoarthritis using surveys, step counts, and laboratory gait analysis.
This study is closed to recruitment; follow-up procedures are completed; the study remains open for data analysis. Enrollment was completed by August 2012.
Read more
As of July 2016, the study is currently analyzing data.
In April 2017 the study was approved to begin long term follow-up with study participants. Study personnel contact participants via telephone and/or U.S. Mail to tell them about long term follow-up, and to ask whether they are willing to continue study participation. Long term follow-up will be for up to 12 years after the participant's ankle surgery.
Read the detailed description
Project Objective:
Ankle osteoarthritis is characterized by joint pain, tenderness, limitation of movement, and variable degrees of inflammation. These factors combined and left untreated will severely limit a person's mobility and willingness to participate in activities. Two common surgical procedures chosen to alleviate pain and to increase mobility are ankle arthrodesis (ankle fusion) and arthroplasty (ankle replacement). Success rates for these procedures are variable and the amount of information available regarding long-term follow-up is limited. The extent to which a person is able and willing to move around the world is often an indicator of his/her condition. The proposed study will examine walking activity levels, and any difference in activity, in patients immediately before and after undergoing surgical treatment for ankle arthritis.
Successfully regaining motility is a priority for patients electing to have surgical treatment for ankle arthritis. A difference in activity levels would indicate an important outcome difference between surgical procedures.
Research Plan:
The investigators propose a mobility outcome study with up to 500 ankle osteoarthritis subjects who will undergo corrective surgery.
Methodology:
The investigators propose a mobility outcome study with a total of up to 500 ankle osteoarthritis subjects before and after surgery over the three years of the study. Ankle arthritis subjects will be recruited from patients at the VA Puget Sound Health Care System (Seattle, WA), Harborview Medical Center (Seattle, WA), Orthopedic + Fracture Specialists (Portland, OR), Orthopaedic Associates of Michigan (Grand Rapids, MN), and Twin Cities Orthopedics (Edina, MN) who have been diagnosed with end stage ankle arthrosis, are ambulatory, speak English, are cognitively intact, and between the ages of 18-80. Recruitment, informed consent procedures and the experimental protocol will be approved by the Institutional Review Board (IRB) at each study site.
Since there is no clinical equipoise it would be unethical to randomize treatment at this time. This project is an observational study of the outcomes following two common treatments: Ankle arthrodesis (fusion) and ankle arthroplasty (total ankle joint replacement). The outcomes will be assessed in two domains:
Functional domain: Each subject's functional status will be determined by the Musculoskeletal Function Assessment (MFA) and the SF-36 general health survey. The MFA is a written questionnaire that assesses activity and social limitations caused by musculoskeletal injury. After completing the questionnaires, subjects will be fit with the Stepwatch Activity Monitor (SAM, Cyma, Seattle WA) around their ankle. An investigator will give them verbal instructions about wearing the SAM. This is a small, pager-sized device which counts the number of steps taken by the wearer. The SAM will be worn around the subject's ankle for 14 days, and then the subject will return the monitor and activity log to the VA by visit or by mail. Assessments using the MFA and SF-36 will occur prior to surgical intervention and at 3, 6, 12, 24, and 36 months following the intervention. Long term follow-up using the MFA and SF-36 was approved in April 2017 and will continue until 12 years after the participant's ankle surgery. Assessments using the SAM will occur prior to surgical intervention and at 3, 6, 12, 24 and 36 months following the intervention. These assessments will provide data on functional limitations due to ankle arthritis and on the efficacy of the treatments in restoring functional ambulation.
Biomechanical domain: Instrumented gait analysis will be performed on each subject. Reflective markers will be placed on each subject's head, hands, arms, trunk, legs, and feet. The subject will walk along a 12 m walkway with embedded forceplates. The motion of the markers will be collected with a 10 camera Vicon 612 system and processed to determine the motion of the ankle joint in three planes as well as the moment and power generated by the ankle during walking. This will allow us to assess the technical functional of the ankle joint, the range of motion used during gait and the moment, power and energy contribution of the ankle during walking for each of the treatments. Gait assessments will occur prior to surgical intervention and at 12, 24, and 36 months post-op. Gait assessment takes place at the VA Puget Sound Health Care System in Seattle, WA. The investigators will only recruit subjects from the VA and Harborview Medical Center for the gait analysis portion of the study.
- Conditions
- Osteoarthritis
- Being tested
- Gait analysis
- Keywords
- ankle osteoarthritis, arthritis, arthrodesis, arthroplasty, Gait, step count, walking
- Medical subject headings
- Osteoarthritis, Arthritis, Ankylosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Gait analysisProcedure or surgery
Subjects will come into motion analysis laboratory at the VA Puget Sound Health Care System. A standard set of body measurements will be taken using calipers, a measuring tape, and a scale (for example height, weight, leg length, foot length, etc). The investigators will then attach small reflective markers to the body using double-sided tape and ask the participants to walk several times as the motion of each marker is recorded by infrared cameras.
| Study group | Role | What they receive |
|---|---|---|
| Group 1 | Subjects undergoing ankle arthrodesis (fusion) for treatment of ankle arthritis Receives: Procedure: Gait analysis | |
| Group 2 | Subjects undergoing ankle arthroplasty (replacement) for treatment of ankle arthritis Receives: Procedure: Gait analysis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Musculoskeletal Functional Assessment (MFA)
Patient reported data using the MFA, a general functional assessment intended as a tool for evaluation of patients' perceptions of their physical, psychological, and social well-being that asks patients to assess their function on 100 items.
Number shows change in outcome from pre-op to 3 years by surgery type, with a lower score implying an improved outcome (scale range 0 -100.)
Measured: Over the course of 3 years
Secondary outcomes (2)
Physical Function Section of Short Form-36 (SF-36)
Patient reported physical function data from the SF-36, a thirty-six item survey evolved from the RAND 36.
Change in outcome from pre-op to 3 years by surgery type, with a higher score implying an improved outcome (scale range 0 - 100.)
Measured: Over the course of 3 years.
Bodily Pain Section of Short Form-36 (SF-36)
Patient reported bodily pain data from the SF-36, a thirty-six item survey evolved from the RAND 36.
Number shows change in outcome from pre-op to 3 years by surgery type, with a higher score implying an improved outcome (scale range 0 - 100.)
Measured: Over the course of 3 years.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Oct 2006 (estimated)
- Study start1 Mar 2005
- Primary completion1 Aug 2015
- Study completion31 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for OsteoarthritisStudies of the same condition, open and under way.
- More trials run by VA Office of Research and DevelopmentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 368 participants (actual)
Sponsor and investigators
- Lead sponsor
- VA Office of Research and Development
- Sponsor type
- US federal agency
- Collaborators
- Orthopaedic Associates of Michigan (Grand Rapids, MI), Orthopedic + Fracture Specialists, Portland, OR, Minnesota Orthopedic Sports Medicine Institute Twin Cities Orthopedics (Edina, MN)
- Responsible party
- Sponsor
- Investigators
- Bruce J. Sangeorzan, MD, Principal investigator, VA Puget Sound Health Care System Seattle Division, Seattle, WA
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00391365
- Sponsor's protocol ID
- F4513-R
- Status last verified
- Jan 2026
- First submitted
- 20 Oct 2006
- Last updated
- 26 Jan 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Segal AD, Cyr KM, Stender CJ, Whittaker EC, Hahn ME, Orendurff MS, Ledoux WR, Sangeorzan BJ. A three-year prospective comparative gait study between patients with ankle arthrodesis and arthroplasty. Clin Biomech (Bristol). 2018 May;54:42-53. doi: 10.1016/j.clinbiomech.2018.02.018. Epub 2018 Mar 5.
PubMed 29550642
Study at a glance
From the registry record, last updated by the sponsor on 26 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Treatment Outcomes for Ankle Arthritis
- ClinicalTrials.gov ID
- NCT00391365
- Acronym / sponsor ID
- F4513-R
- Conditions
- Osteoarthritis
- Keywords
- ankle osteoarthritis, arthritis, arthrodesis, arthroplasty, Gait, step count, walking
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 368 participants (actual)
- Lead sponsor
- VA Office of Research and DevelopmentUS federal agency
- Collaborators
- Orthopaedic Associates of Michigan (Grand Rapids, MI), Orthopedic + Fracture Specialists, Portland, OR, Minnesota Orthopedic Sports Medicine Institute Twin Cities Orthopedics (Edina, MN)
- Study start
- 1 Mar 2005 (actual)
- Primary completion
- 1 Aug 2015 (actual)
- Study completion
- 31 Dec 2025 (actual)
- First posted
- 24 Oct 2006 (estimated)
- Results
- Posted 21 Dec 2016
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine any functional outcome differences in patients who have undergone surgical treatment for ankle osteoarthritis using surveys, step counts, and laboratory gait analysis.
This study is closed to recruitment; follow-up procedures are completed; the study remains open for data analysis. Enrollment was completed by August 2012.
As of July 2016, the study is currently analyzing data.
In April 2017 the study was approved to begin long term follow-up with study participants. Study personnel contact participants via telephone and/or U.S. Mail to tell them about long term follow-up, and to ask whether they are willing to continue study participation. Long term follow-up will be for up to 12 years after the participant's ankle surgery.
Detailed description
Project Objective:
Ankle osteoarthritis is characterized by joint pain, tenderness, limitation of movement, and variable degrees of inflammation. These factors combined and left untreated will severely limit a person's mobility and willingness to participate in activities. Two common surgical procedures chosen to alleviate pain and to increase mobility are ankle arthrodesis (ankle fusion) and arthroplasty (ankle replacement). Success rates for these procedures are variable and the amount of information available regarding long-term follow-up is limited. The extent to which a person is able and willing to move around the world is often an indicator of his/her condition. The proposed study will examine walking activity levels, and any difference in activity, in patients immediately before and after undergoing surgical treatment for ankle arthritis.
Successfully regaining motility is a priority for patients electing to have surgical treatment for ankle arthritis. A difference in activity levels would indicate an important outcome difference between surgical procedures.
Research Plan:
The investigators propose a mobility outcome study with up to 500 ankle osteoarthritis subjects who will undergo corrective surgery.
Methodology:
The investigators propose a mobility outcome study with a total of up to 500 ankle osteoarthritis subjects before and after surgery over the three years of the study. Ankle arthritis subjects will be recruited from patients at the VA Puget Sound Health Care System (Seattle, WA), Harborview Medical Center (Seattle, WA), Orthopedic + Fracture Specialists (Portland, OR), Orthopaedic Associates of Michigan (Grand Rapids, MN), and Twin Cities Orthopedics (Edina, MN) who have been diagnosed with end stage ankle arthrosis, are ambulatory, speak English, are cognitively intact, and between the ages of 18-80. Recruitment, informed consent procedures and the experimental protocol will be approved by the Institutional Review Board (IRB) at each study site.
Since there is no clinical equipoise it would be unethical to randomize treatment at this time. This project is an observational study of the outcomes following two common treatments: Ankle arthrodesis (fusion) and ankle arthroplasty (total ankle joint replacement). The outcomes will be assessed in two domains:
Functional domain: Each subject's functional status will be determined by the Musculoskeletal Function Assessment (MFA) and the SF-36 general health survey. The MFA is a written questionnaire that assesses activity and social limitations caused by musculoskeletal injury. After completing the questionnaires, subjects will be fit with the Stepwatch Activity Monitor (SAM, Cyma, Seattle WA) around their ankle. An investigator will give them verbal instructions about wearing the SAM. This is a small, pager-sized device which counts the number of steps taken by the wearer. The SAM will be worn around the subject's ankle for 14 days, and then the subject will return the monitor and activity log to the VA by visit or by mail. Assessments using the MFA and SF-36 will occur prior to surgical intervention and at 3, 6, 12, 24, and 36 months following the intervention. Long term follow-up using the MFA and SF-36 was approved in April 2017 and will continue until 12 years after the participant's ankle surgery. Assessments using the SAM will occur prior to surgical intervention and at 3, 6, 12, 24 and 36 months following the intervention. These assessments will provide data on functional limitations due to ankle arthritis and on the efficacy of the treatments in restoring functional ambulation.
Biomechanical domain: Instrumented gait analysis will be performed on each subject. Reflective markers will be placed on each subject's head, hands, arms, trunk, legs, and feet. The subject will walk along a 12 m walkway with embedded forceplates. The motion of the markers will be collected with a 10 camera Vicon 612 system and processed to determine the motion of the ankle joint in three planes as well as the moment and power generated by the ankle during walking. This will allow us to assess the technical functional of the ankle joint, the range of motion used during gait and the moment, power and energy contribution of the ankle during walking for each of the treatments. Gait assessments will occur prior to surgical intervention and at 12, 24, and 36 months post-op. Gait assessment takes place at the VA Puget Sound Health Care System in Seattle, WA. The investigators will only recruit subjects from the VA and Harborview Medical Center for the gait analysis portion of the study.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group 1 | – | Procedure: Gait analysisSubjects undergoing ankle arthrodesis (fusion) for treatment of ankle arthritis |
| Group 2 | – | Procedure: Gait analysisSubjects undergoing ankle arthroplasty (replacement) for treatment of ankle arthritis |
Who may qualify
- Ages
- 18 to 89 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Subjects with ankle osteoarthritis who will undergo either ankle arthrodesis (fusion) or ankle arthroplasty (replacement)
Key inclusion criteria (12 listed)
- Ankle arthritis subjects will be recruited from patients at
- who have been diagnosed with end stage ankle arthrosis
- are ambulatory
- speak English
- are cognitively intact
Key exclusion criteria (2 listed)
- Suffer from Rheumatoid Arthritis or other systemic arthritis
- Have any other diseased lower extremity joints or traumatic lower extremity injury that grossly inhibits normal gait
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Gait analysisSubjects will come into motion analysis laboratory at the VA Puget Sound Health Care System. A standard set of body measurements will be taken using calipers, a measuring tape, and a scale (for example height, weight, leg length, foot length, etc). The investigators will then attach small reflective markers to the body using double-sided tape and ask the participants to walk several times as the motion of each marker is recorded by infrared cameras. | Procedure or surgery | Group 1, Group 2 |
Primary outcome
Musculoskeletal Functional Assessment (MFA)
Time frame: Over the course of 3 years
Patient reported data using the MFA, a general functional assessment intended as a tool for evaluation of patients' perceptions of their physical, psychological, and social well-being that asks patients to assess their function on 100 items. Number shows change in outcome from pre-op to 3 years by surgery type, with a lower score implying an improved outcome (scale range 0 -100.)
2 secondary outcomes
Physical Function Section of Short Form-36 (SF-36)
Time frame: Over the course of 3 years.
Bodily Pain Section of Short Form-36 (SF-36)
Time frame: Over the course of 3 years.
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jan 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 29550642Segal AD, Cyr KM, Stender CJ, Whittaker EC, Hahn ME, Orendurff MS, Ledoux WR, Sangeorzan BJ. A three-year prospective comparative gait study between patients with ankle arthrodesis and arthroplasty. Clin Biomech (Bristol). 2018 May;54:42-53. doi: 10.1016/j.clinbiomech.2018.02.018. Epub 2018 Mar 5.
- Individual participant dataSharing planned: No
Related trials for Osteoarthritis
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Active, not recruiting
Effectiveness of Therapeutic Exercises on Spinopelvic Mobility
Osteoarthritis (OA) of the Hip
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Bruce J. Sangeorzan, MD principal investigator
VA Puget Sound Health Care System Seattle Division, Seattle, WA
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Osteoarthritis, run by VA Office of Research and Development at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 12 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 21 Dec 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Musculoskeletal Functional Assessment (MFA) (time frame: Over the course of 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00391365, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2026.